Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
3 Emerging Pharmaceutical Market: Brazil – Industry Characterstics
3.1 Market Size and Market Forecast
3.2 Market Share by Therapy Area
3.3 Branded versus Generic Market Share
3.4 R&D Expenditure Innovations
3.4.1 Increased Screening Rates during R&D
3.5 Top Pharmaceutical Companies in Brazil
3.5.1 Domestic Players
3.5.2 Foreign Players
3.6 Drivers and Challenges
3.6.1 Drivers
3.6.2 Barriers
3.7 Healthcare Delivery System
3.7.1 Brazil Healthcare Delivery Opportunities
3.7.2 Brazil Healthcare Delivery Challenges
3.8 PESTLE Analysis
3.8.1 Political factors
3.8.2 Economic factors
3.8.3 Social factors
3.8.4 Technological factors
3.8.5 Legal factors
3.8.6 Environmental factors
4 Emerging Pharmaceutical Market: Brazil – Macroeconomic Environment
4.1 Demographic Analysis
4.1.1 Population Size, Growth, and Structure
4.1.2 Disease Overview in Brazil
4.2 GDP
4.3 Per Capita Income
4.3.1 Context
4.3.2 Analytical Framework
4.4 Healthcare Expenditure
4.4.1 Context
4.4.2 Analytical Framework
4.5 Healthcare Infrastructure
4.5.1 Analytical Framework
5 Emerging Pharmaceutical Market: Brazil -Healthcare Regulation
5.1 Pharmaceutical Regulation in Brazil
5.2 Drug Approval Process
5.3 Drug Registration Process
5.4 Patents and Generics (IPR)
5.5 Health Insurance Coverage
5.6 Clinical Trials
5.6.1 Context
5.6.2 Analytical Framework
5.7 Pricing and Reimbursement
5.7.1 Private Insurance
5.7.2 Hospotels
5.7.3 Cosmetic Travel
5.8 Regulatory Bodies
5.8.1 Ministry of Health (MOH)
5.8.2 Unified Health System (UHS also called as SUS in Brazil)
6 Emerging Pharmaceutical Market: Brazil - Industry Trends
6.1 Mergers and Acquisitions
6.1.1 M&A Deals by Year
6.1.2 Deal by Value
6.1.3 Recent M&A Deals
6.1.4 Top Five M&As
6.2 Co-development Deals
6.2.1 Deals by Year
6.2.2 Deal by Value
6.2.3 Recent Co-development Deals
6.2.4 Top Co-development Deals
6.3 Licensing Agreements
6.3.1 Deals by Year
6.3.2 Deals by Value
6.3.3 Recent Licensing Agreements
6.3.4 Top Licensing Agreements
7 Emerging Pharmaceutical Market: Brazil – CRO Industry
7.1 Contract Research Organization (CRO) Market Size and Growth
7.1.1 PPD
7.1.2 PRA International
7.1.3 ICON
7.1.4 Theorem Clinical Research
7.1.5 PAREXEL
7.1.6 Intrials
7.1.7 Eurotrials
7.1.8 PGS Medical/Statistics
7.1.9 INC Research
7.1.10 Chiltern
7.1.11 Covance
7.1.12 Quintiles
8 Emerging Pharmaceutical Market: Brazil – Appendix
8.1 Market Definitions
8.2 Abbreviations
8.3 Sources
8.4 Research Methodology
8.4.1 Industry Performance
8.4.2 Macroeconomic Environment
8.4.3 Healthcare Regulations
8.4.4 Industry Trends
8.5 Contact Us
8.6 Disclaimer